Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults

Two antigenically distinct influenza B lineage viruses (Yamagata/Victoria) have been co-circulating globally since the mid-1980s. The quadrivalent influenza vaccine (QIV) may provide better protection against unpredictable B strains. We conducted a randomized, double-blind, phase III trial to evalua...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: Song, Joon Young, Lee, Jacob, Woo, Heung Jeong, Wie, Seong-Heon, Lee, Jin Soo, Kim, Shin Woo, Kim, Tae Hyong, Jung, Sook-In, Noh, Ji Yun, Choi, Won Suk, Cheong, Hee Jin, Kim, Woo Joo
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2018
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6605850/
https://ncbi.nlm.nih.gov/pubmed/30396317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1536589
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires